Selasa, 17 Desember 2013
antitrust
Fentanyl
Johnson and Johnson
mission-hostile management
narcotics
Netherlands
Novartis
restraint of competition
The Camel's Aching Back - Johnson and Johnson and Novartis Fined 16 Million Euro for "Anticompetitive" Scheme to Delay Generic Fentanyl
Legal and regulatory actions unfavorable for giant pharmaceutical, biotechnology and device company Johnson and Johnson just keep coming. W...